 | • レポートコード：QFJ1-4353 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、膿痂疹治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（セファロスポリン、フシダン、リンコサミド抗生物質、ペニシリン、ペニシリン様抗生物質、プレウロムチリン、プセドモニック酸A、キノロン、スルホンアミド＆葉酸阻害剤、テトラサイクリン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・膿痂疹治療の市場動向 ・企業の競争状況、市場シェア ・膿痂疹治療の種類別市場規模と予測2016-2027（セファロスポリン、フシダン、リンコサミド抗生物質、ペニシリン、ペニシリン様抗生物質、プレウロムチリン、プセドモニック酸A、キノロン、スルホンアミド＆葉酸阻害剤、テトラサイクリン） ・膿痂疹治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・膿痂疹治療の北米市場規模2016-2027（アメリカ、カナダ） ・膿痂疹治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・膿痂疹治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・膿痂疹治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・膿痂疹治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline plc、Karalex Pharma, LLC、Leo Pharma A/S、Lupin Limited、NovaBay Pharmaceuticals, Inc.、Pfizer, Inc.、Ranbaxy Laboratories Limited、Roche Holding AG、SANDOZ GmbH、Taro Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd） ・結論 |
Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.
Market Analysis and Insights: Global Impetigo Treatment Market
The global Impetigo Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Impetigo Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Impetigo Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Impetigo Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Impetigo Treatment market.
Global Impetigo Treatment Scope and Market Size
Impetigo Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Impetigo Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cephalosporins
Fusidane
Lincosamide Antibiotic
Penicillin
Penicillin-Like Antibiotics
Pleuromutilin
Pseudomonic Acid A
Quinolone
Sulfonamides And Folic Acid Inhibitors
Tetracyclines
Segment by Application
Hospitals
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline plc
Karalex Pharma, LLC
Leo Pharma A/S
Lupin Limited
NovaBay Pharmaceuticals, Inc.
Pfizer, Inc.
Ranbaxy Laboratories Limited
Roche Holding AG
SANDOZ GmbH
Taro Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Impetigo Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cephalosporins
1.2.3 Fusidane
1.2.4 Lincosamide Antibiotic
1.2.5 Penicillin
1.2.6 Penicillin-Like Antibiotics
1.2.7 Pleuromutilin
1.2.8 Pseudomonic Acid A
1.2.9 Quinolone
1.2.10 Sulfonamides And Folic Acid Inhibitors
1.2.11 Tetracyclines
1.3 Market by Application
1.3.1 Global Impetigo Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Impetigo Treatment Market Perspective (2016-2027)
2.2 Impetigo Treatment Growth Trends by Regions
2.2.1 Impetigo Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Impetigo Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Impetigo Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Impetigo Treatment Industry Dynamic
2.3.1 Impetigo Treatment Market Trends
2.3.2 Impetigo Treatment Market Drivers
2.3.3 Impetigo Treatment Market Challenges
2.3.4 Impetigo Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Impetigo Treatment Players by Revenue
3.1.1 Global Top Impetigo Treatment Players by Revenue (2016-2021)
3.1.2 Global Impetigo Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Impetigo Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Impetigo Treatment Revenue
3.4 Global Impetigo Treatment Market Concentration Ratio
3.4.1 Global Impetigo Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Impetigo Treatment Revenue in 2020
3.5 Impetigo Treatment Key Players Head office and Area Served
3.6 Key Players Impetigo Treatment Product Solution and Service
3.7 Date of Enter into Impetigo Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Impetigo Treatment Breakdown Data by Type
4.1 Global Impetigo Treatment Historic Market Size by Type (2016-2021)
4.2 Global Impetigo Treatment Forecasted Market Size by Type (2022-2027)
5 Impetigo Treatment Breakdown Data by Application
5.1 Global Impetigo Treatment Historic Market Size by Application (2016-2021)
5.2 Global Impetigo Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Impetigo Treatment Market Size (2016-2027)
6.2 North America Impetigo Treatment Market Size by Type
6.2.1 North America Impetigo Treatment Market Size by Type (2016-2021)
6.2.2 North America Impetigo Treatment Market Size by Type (2022-2027)
6.2.3 North America Impetigo Treatment Market Size by Type (2016-2027)
6.3 North America Impetigo Treatment Market Size by Application
6.3.1 North America Impetigo Treatment Market Size by Application (2016-2021)
6.3.2 North America Impetigo Treatment Market Size by Application (2022-2027)
6.3.3 North America Impetigo Treatment Market Size by Application (2016-2027)
6.4 North America Impetigo Treatment Market Size by Country
6.4.1 North America Impetigo Treatment Market Size by Country (2016-2021)
6.4.2 North America Impetigo Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Impetigo Treatment Market Size (2016-2027)
7.2 Europe Impetigo Treatment Market Size by Type
7.2.1 Europe Impetigo Treatment Market Size by Type (2016-2021)
7.2.2 Europe Impetigo Treatment Market Size by Type (2022-2027)
7.2.3 Europe Impetigo Treatment Market Size by Type (2016-2027)
7.3 Europe Impetigo Treatment Market Size by Application
7.3.1 Europe Impetigo Treatment Market Size by Application (2016-2021)
7.3.2 Europe Impetigo Treatment Market Size by Application (2022-2027)
7.3.3 Europe Impetigo Treatment Market Size by Application (2016-2027)
7.4 Europe Impetigo Treatment Market Size by Country
7.4.1 Europe Impetigo Treatment Market Size by Country (2016-2021)
7.4.2 Europe Impetigo Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Impetigo Treatment Market Size (2016-2027)
8.2 Asia-Pacific Impetigo Treatment Market Size by Type
8.2.1 Asia-Pacific Impetigo Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Impetigo Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Impetigo Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Impetigo Treatment Market Size by Application
8.3.1 Asia-Pacific Impetigo Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Impetigo Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Impetigo Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Impetigo Treatment Market Size by Region
8.4.1 Asia-Pacific Impetigo Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Impetigo Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Impetigo Treatment Market Size (2016-2027)
9.2 Latin America Impetigo Treatment Market Size by Type
9.2.1 Latin America Impetigo Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Impetigo Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Impetigo Treatment Market Size by Type (2016-2027)
9.3 Latin America Impetigo Treatment Market Size by Application
9.3.1 Latin America Impetigo Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Impetigo Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Impetigo Treatment Market Size by Application (2016-2027)
9.4 Latin America Impetigo Treatment Market Size by Country
9.4.1 Latin America Impetigo Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Impetigo Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Impetigo Treatment Market Size (2016-2027)
10.2 Middle East & Africa Impetigo Treatment Market Size by Type
10.2.1 Middle East & Africa Impetigo Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Impetigo Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Impetigo Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Impetigo Treatment Market Size by Application
10.3.1 Middle East & Africa Impetigo Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Impetigo Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Impetigo Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Impetigo Treatment Market Size by Country
10.4.1 Middle East & Africa Impetigo Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Impetigo Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Details
11.1.2 GlaxoSmithKline plc Business Overview
11.1.3 GlaxoSmithKline plc Impetigo Treatment Introduction
11.1.4 GlaxoSmithKline plc Revenue in Impetigo Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline plc Recent Development
11.2 Karalex Pharma, LLC
11.2.1 Karalex Pharma, LLC Company Details
11.2.2 Karalex Pharma, LLC Business Overview
11.2.3 Karalex Pharma, LLC Impetigo Treatment Introduction
11.2.4 Karalex Pharma, LLC Revenue in Impetigo Treatment Business (2016-2021)
11.2.5 Karalex Pharma, LLC Recent Development
11.3 Leo Pharma A/S
11.3.1 Leo Pharma A/S Company Details
11.3.2 Leo Pharma A/S Business Overview
11.3.3 Leo Pharma A/S Impetigo Treatment Introduction
11.3.4 Leo Pharma A/S Revenue in Impetigo Treatment Business (2016-2021)
11.3.5 Leo Pharma A/S Recent Development
11.4 Lupin Limited
11.4.1 Lupin Limited Company Details
11.4.2 Lupin Limited Business Overview
11.4.3 Lupin Limited Impetigo Treatment Introduction
11.4.4 Lupin Limited Revenue in Impetigo Treatment Business (2016-2021)
11.4.5 Lupin Limited Recent Development
11.5 NovaBay Pharmaceuticals, Inc.
11.5.1 NovaBay Pharmaceuticals, Inc. Company Details
11.5.2 NovaBay Pharmaceuticals, Inc. Business Overview
11.5.3 NovaBay Pharmaceuticals, Inc. Impetigo Treatment Introduction
11.5.4 NovaBay Pharmaceuticals, Inc. Revenue in Impetigo Treatment Business (2016-2021)
11.5.5 NovaBay Pharmaceuticals, Inc. Recent Development
11.6 Pfizer, Inc.
11.6.1 Pfizer, Inc. Company Details
11.6.2 Pfizer, Inc. Business Overview
11.6.3 Pfizer, Inc. Impetigo Treatment Introduction
11.6.4 Pfizer, Inc. Revenue in Impetigo Treatment Business (2016-2021)
11.6.5 Pfizer, Inc. Recent Development
11.7 Ranbaxy Laboratories Limited
11.7.1 Ranbaxy Laboratories Limited Company Details
11.7.2 Ranbaxy Laboratories Limited Business Overview
11.7.3 Ranbaxy Laboratories Limited Impetigo Treatment Introduction
11.7.4 Ranbaxy Laboratories Limited Revenue in Impetigo Treatment Business (2016-2021)
11.7.5 Ranbaxy Laboratories Limited Recent Development
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Details
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG Impetigo Treatment Introduction
11.8.4 Roche Holding AG Revenue in Impetigo Treatment Business (2016-2021)
11.8.5 Roche Holding AG Recent Development
11.9 SANDOZ GmbH
11.9.1 SANDOZ GmbH Company Details
11.9.2 SANDOZ GmbH Business Overview
11.9.3 SANDOZ GmbH Impetigo Treatment Introduction
11.9.4 SANDOZ GmbH Revenue in Impetigo Treatment Business (2016-2021)
11.9.5 SANDOZ GmbH Recent Development
11.10 Taro Pharmaceutical Industries Ltd
11.10.1 Taro Pharmaceutical Industries Ltd Company Details
11.10.2 Taro Pharmaceutical Industries Ltd Business Overview
11.10.3 Taro Pharmaceutical Industries Ltd Impetigo Treatment Introduction
11.10.4 Taro Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2016-2021)
11.10.5 Taro Pharmaceutical Industries Ltd Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Details
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Impetigo Treatment Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2016-2021)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Impetigo Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cephalosporins
Table 3. Key Players of Fusidane
Table 4. Key Players of Lincosamide Antibiotic
Table 5. Key Players of Penicillin
Table 6. Key Players of Penicillin-Like Antibiotics
Table 7. Key Players of Pleuromutilin
Table 8. Key Players of Pseudomonic Acid A
Table 9. Key Players of Quinolone
Table 10. Key Players of Sulfonamides And Folic Acid Inhibitors
Table 11. Key Players of Tetracyclines
Table 12. Global Impetigo Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Impetigo Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 14. Global Impetigo Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 15. Global Impetigo Treatment Market Share by Regions (2016-2021)
Table 16. Global Impetigo Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 17. Global Impetigo Treatment Market Share by Regions (2022-2027)
Table 18. Impetigo Treatment Market Trends
Table 19. Impetigo Treatment Market Drivers
Table 20. Impetigo Treatment Market Challenges
Table 21. Impetigo Treatment Market Restraints
Table 22. Global Impetigo Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 23. Global Impetigo Treatment Market Share by Players (2016-2021)
Table 24. Global Top Impetigo Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Impetigo Treatment as of 2020)
Table 25. Ranking of Global Top Impetigo Treatment Companies by Revenue (US$ Million) in 2020
Table 26. Global 5 Largest Players Market Share by Impetigo Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Impetigo Treatment Product Solution and Service
Table 29. Date of Enter into Impetigo Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Impetigo Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. Global Impetigo Treatment Revenue Market Share by Type (2016-2021)
Table 33. Global Impetigo Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 34. Global Impetigo Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 35. Global Impetigo Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 36. Global Impetigo Treatment Revenue Market Share by Application (2016-2021)
Table 37. Global Impetigo Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 38. Global Impetigo Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 39. North America Impetigo Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. North America Impetigo Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. North America Impetigo Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. North America Impetigo Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. North America Impetigo Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. North America Impetigo Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Europe Impetigo Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Europe Impetigo Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Europe Impetigo Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Europe Impetigo Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Europe Impetigo Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 50. Europe Impetigo Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Impetigo Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Asia-Pacific Impetigo Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Impetigo Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Asia-Pacific Impetigo Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Impetigo Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 56. Asia-Pacific Impetigo Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 57. Latin America Impetigo Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Latin America Impetigo Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Latin America Impetigo Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Latin America Impetigo Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Latin America Impetigo Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Latin America Impetigo Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Impetigo Treatment Market Size by Type (2016-2021) (US$ Million)
Table 64. Middle East & Africa Impetigo Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Impetigo Treatment Market Size by Application (2016-2021) (US$ Million)
Table 66. Middle East & Africa Impetigo Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 67. Middle East & Africa Impetigo Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 68. Middle East & Africa Impetigo Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 69. GlaxoSmithKline plc Company Details
Table 70. GlaxoSmithKline plc Business Overview
Table 71. GlaxoSmithKline plc Impetigo Treatment Product
Table 72. GlaxoSmithKline plc Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline plc Recent Development
Table 74. Karalex Pharma, LLC Company Details
Table 75. Karalex Pharma, LLC Business Overview
Table 76. Karalex Pharma, LLC Impetigo Treatment Product
Table 77. Karalex Pharma, LLC Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 78. Karalex Pharma, LLC Recent Development
Table 79. Leo Pharma A/S Company Details
Table 80. Leo Pharma A/S Business Overview
Table 81. Leo Pharma A/S Impetigo Treatment Product
Table 82. Leo Pharma A/S Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 83. Leo Pharma A/S Recent Development
Table 84. Lupin Limited Company Details
Table 85. Lupin Limited Business Overview
Table 86. Lupin Limited Impetigo Treatment Product
Table 87. Lupin Limited Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 88. Lupin Limited Recent Development
Table 89. NovaBay Pharmaceuticals, Inc. Company Details
Table 90. NovaBay Pharmaceuticals, Inc. Business Overview
Table 91. NovaBay Pharmaceuticals, Inc. Impetigo Treatment Product
Table 92. NovaBay Pharmaceuticals, Inc. Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 93. NovaBay Pharmaceuticals, Inc. Recent Development
Table 94. Pfizer, Inc. Company Details
Table 95. Pfizer, Inc. Business Overview
Table 96. Pfizer, Inc. Impetigo Treatment Product
Table 97. Pfizer, Inc. Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 98. Pfizer, Inc. Recent Development
Table 99. Ranbaxy Laboratories Limited Company Details
Table 100. Ranbaxy Laboratories Limited Business Overview
Table 101. Ranbaxy Laboratories Limited Impetigo Treatment Product
Table 102. Ranbaxy Laboratories Limited Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 103. Ranbaxy Laboratories Limited Recent Development
Table 104. Roche Holding AG Company Details
Table 105. Roche Holding AG Business Overview
Table 106. Roche Holding AG Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 107. Roche Holding AG Recent Development
Table 108. SANDOZ GmbH Company Details
Table 109. SANDOZ GmbH Business Overview
Table 110. SANDOZ GmbH Impetigo Treatment Product
Table 111. SANDOZ GmbH Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 112. SANDOZ GmbH Recent Development
Table 113. Taro Pharmaceutical Industries Ltd Company Details
Table 114. Taro Pharmaceutical Industries Ltd Business Overview
Table 115. Taro Pharmaceutical Industries Ltd Impetigo Treatment Product
Table 116. Taro Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 117. Taro Pharmaceutical Industries Ltd Recent Development
Table 118. Teva Pharmaceutical Industries Ltd Company Details
Table 119. Teva Pharmaceutical Industries Ltd Business Overview
Table 120. Teva Pharmaceutical Industries Ltd Impetigo Treatment Product
Table 121. Teva Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2016-2021) & (US$ Million)
Table 122. Teva Pharmaceutical Industries Ltd Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Impetigo Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cephalosporins Features
Figure 3. Fusidane Features
Figure 4. Lincosamide Antibiotic Features
Figure 5. Penicillin Features
Figure 6. Penicillin-Like Antibiotics Features
Figure 7. Pleuromutilin Features
Figure 8. Pseudomonic Acid A Features
Figure 9. Quinolone Features
Figure 10. Sulfonamides And Folic Acid Inhibitors Features
Figure 11. Tetracyclines Features
Figure 12. Global Impetigo Treatment Market Share by Application: 2020 VS 2027
Figure 13. Hospitals Case Studies
Figure 14. Clinic Case Studies
Figure 15. Others Case Studies
Figure 16. Impetigo Treatment Report Years Considered
Figure 17. Global Impetigo Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Impetigo Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Impetigo Treatment Market Share by Regions: 2020 VS 2027
Figure 20. Global Impetigo Treatment Market Share by Regions (2022-2027)
Figure 21. Global Impetigo Treatment Market Share by Players in 2020
Figure 22. Global Top Impetigo Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Impetigo Treatment as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Impetigo Treatment Revenue in 2020
Figure 24. Global Impetigo Treatment Revenue Market Share by Type (2016-2021)
Figure 25. Global Impetigo Treatment Revenue Market Share by Type (2022-2027)
Figure 26. North America Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Impetigo Treatment Market Share by Type (2016-2027)
Figure 28. North America Impetigo Treatment Market Share by Application (2016-2027)
Figure 29. North America Impetigo Treatment Market Share by Country (2016-2027)
Figure 30. United States Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Impetigo Treatment Market Share by Type (2016-2027)
Figure 34. Europe Impetigo Treatment Market Share by Application (2016-2027)
Figure 35. Europe Impetigo Treatment Market Share by Country (2016-2027)
Figure 36. Germany Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Impetigo Treatment Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Impetigo Treatment Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Impetigo Treatment Market Share by Region (2016-2027)
Figure 46. China Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Impetigo Treatment Market Share by Type (2016-2027)
Figure 54. Latin America Impetigo Treatment Market Share by Application (2016-2027)
Figure 55. Latin America Impetigo Treatment Market Share by Country (2016-2027)
Figure 56. Mexico Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Impetigo Treatment Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Impetigo Treatment Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Impetigo Treatment Market Share by Country (2016-2027)
Figure 62. Turkey Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Impetigo Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. GlaxoSmithKline plc Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 66. Karalex Pharma, LLC Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 67. Leo Pharma A/S Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 68. Lupin Limited Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 69. NovaBay Pharmaceuticals, Inc. Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 70. Pfizer, Inc. Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 71. Ranbaxy Laboratories Limited Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 72. Roche Holding AG Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 73. SANDOZ GmbH Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 74. Taro Pharmaceutical Industries Ltd Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 75. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Impetigo Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
膿痂疹治療のグローバル市場：規模・現状・予測2019-2025 Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.In 2018, the global Impetigo Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses …- 膿痂疹治療のグローバル市場：規模・現状・予測2019-2025 Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.In 2018, the global Impetigo Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses …
- 膿痂疹治療のグローバル市場：規模・現状・予測2019-2025 Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.In 2018, the global Impetigo Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses …
- 葉酸のグローバル市場2021 Folic Acid, also called vitamin B9, is a type of water-soluble B vitamin that is naturally present in some foods, added to others, and available as a dietary supplement. The Folic Acid industry concentration is very high; there are several manufacturers in the world, and located in Europe and China.…
- 膿痂疹薬のグローバル市場調査 2019年 The global Impetigo Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Impetigo Drug volume and value at global level, regional level and company level. From a global perspective, this report repr…